Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: May 20, 2022
Context: This filing serves as a cover document to disclose material events and financial results for the fourth quarter (Q4) and full fiscal year (FY) 2022. It includes intimations regarding disclosures under SEBI Regulation 30 and a newspaper advertisement concerning financial results.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data. The filing references attached exhibits (99.2, 99.3, 99.4) that contain the actual financial results for Q4 and FY2022. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. It indicates that such information is contained within the attached exhibits regarding the Q4 and FY2022 financial results.
Guidance, Outlook, and Risks
No management commentary, guidance, outlook, risks, contingencies, or unusual items are detailed in the provided text. The document strictly lists the submission of results and regulatory intimations.
Investor Verification Checklist
- Review Exhibit 99.4 for the specific newspaper advertisement containing Q4 and FY2022 financial figures.
- Examine Exhibit 99.2 and 99.3 for the full text of the SEBI Regulation 30 disclosure intimations.
- Verify the exact revenue, net profit, and EPS figures for the period ended March 31, 2022, in the attached exhibits as they are absent from this cover sheet.